Literature DB >> 22894580

Quality of life and guidelines for PSA screening.

Harold C Sox.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22894580     DOI： 10.1056/NEJMe1207165

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Prostate Cancer Screening.

Authors:  William J Catalona
Journal:  Med Clin North Am       Date:  2018-03       Impact factor: 5.456

2.  Do clinical guidelines still make sense? Yes.

Authors:  Harold C Sox
Journal:  Ann Fam Med       Date:  2014 May-Jun       Impact factor: 5.166

3.  Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies.

Authors:  Joshua A Roth; Roman Gulati; John L Gore; Matthew R Cooperberg; Ruth Etzioni
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

4.  Comparative Effectiveness Research: A Roadmap for Physical Activity and Lifestyle.

Authors:  John M Jakicic; Harold Sox; Steven N Blair; Mark Bensink; William G Johnson; Abby C King; I-Min Lee; Inbal Nahum-Shani; James F Sallis; Robert E Sallis; Lynette Craft; James R Whitehead; Barbara E Ainsworth
Journal:  Med Sci Sports Exerc       Date:  2015-08       Impact factor: 5.411

5.  Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.

Authors:  E A M Heijnsdijk; T M de Carvalho; A Auvinen; M Zappa; V Nelen; M Kwiatkowski; A Villers; A Páez; S M Moss; T L J Tammela; F Recker; L Denis; S V Carlsson; E M Wever; C H Bangma; F H Schröder; M J Roobol; J Hugosson; H J de Koning
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

6.  Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors:  Roman Gulati; John L Gore; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

7.  Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.

Authors:  Oguzhan Alagoz; Donald A Berry; Harry J de Koning; Eric J Feuer; Sandra J Lee; Sylvia K Plevritis; Clyde B Schechter; Natasha K Stout; Amy Trentham-Dietz; Jeanne S Mandelblatt
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

8.  A Framework for Treatment Decision Making at Prostate Cancer Recurrence.

Authors:  Jane M Lange; Bruce J Trock; Roman Gulati; Ruth Etzioni
Journal:  Med Decis Making       Date:  2017-05-31       Impact factor: 2.583

Review 9.  What do the screening trials really tell us and where do we go from here?

Authors:  Ruth D Etzioni; Ian M Thompson
Journal:  Urol Clin North Am       Date:  2014-02-19       Impact factor: 2.241

10.  A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.

Authors:  Murray D Krahn; Karen E Bremner; Shabbir M H Alibhai; Andy Ni; George Tomlinson; Audrey Laporte; Gary Naglie
Journal:  Qual Life Res       Date:  2013-04-06       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.